Pdt Partners, LLC Olema Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.55 - $4.97 $32,744 - $63,819	-12,841 Reduced 54.84%	10,573 $36,000
Q4 2022 Feb 14, 2023	SELL	$2.27 - $3.76 $29,798 - $49,357	-13,127 Reduced 35.92%	23,414 $57,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $151,811 - $328,180	-55,813 Reduced 60.43%	36,541 $101,000
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $61,208 - $138,318	-30,004 Reduced 24.52%	92,354 $376,000
Q1 2022 May 16, 2022	BUY	$3.89 - $9.43 $378,065 - $916,492	97,189 Added 386.15%	122,358 $521,000
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $220,228 - $772,939	25,169 New	25,169 $236,000

143

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $258M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.